Skip to content

Acrivon Therapeutics, Inc.

ACRV· Nasdaqxbrl foundCIK 1781174

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -8.54%
Market cap
$61.92M
42.85M shares
Filings
351
—
—
—
-$17.96M
Q2 2026N/M FY25 yoy
-$18.67M
Q2 2026N/M FY25 yoy
-$35.50M
Q2 2026derivedN/M FY25 yoy
-$0.43
Q2 2026N/M FY25 yoy
$41.42M
Q2 2026+4.2% FY25 yoy
$61.92M
—
—
0.7×
-105.51%
—

FY2025 figures · derived

Price

$1.4530.19%$0.62past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$59.99MFY 2025
$63.99M0FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$59,990,000reported
FY 20242024-12-31$63,992,000reported
FY 20232023-12-31$46,024,000reported
FY 20222022-12-31$23,949,000reported

Segments

Geography
Long-lived assets by Geography, FY2023 to FY2025FY2023United States · FY2023 · $5.70MLund, Sweden · FY2023 · $2.20MFY2024United States · FY2024 · $4.90MLund, Sweden · FY2024 · $3.10MFY2025United States · FY2025 · $5.10MLund, Sweden · FY2025 · $2.30M
LineFY2025ShareChange
United States$5.10M104%+4.1%
Lund, Sweden$2.30M47%−25.8%
Total$4.89M

From the 10-K filed Mar 19, 2026ACRV

Pharmaceutical preparations

Acrivon Therapeutics, Inc. is the 320th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Acrivon Therapeutics, Inc. · CIK 1781174 · Engraved from SEC EDGAR